Phencyclidine-like effects of tetrahydroisoquinolines and related compounds

Citations Over Time

Abstract

A series of 1,2,3,4-tetrahydroisoquinolines, tetrahydrothieno[2,3-c]pyridines, and related compounds were evaluated for their ability to inhibit binding of [3H]-1-[1-(2-thienyl)piperidine and [3H]-N-allylnormetazocine to phencyclidine (PCP) and sigma receptors, respectively. A representative series of compounds was evaluated in behavioral assays to determine the ability of the compounds to induce PCP-like stereotyped behavior and ataxia. All of the compounds caused stereotyped behavior and ataxia, indicating their agonist actions at the PCP site.

Related Papers

• → Sigma opioid receptor: characterization and co-identity with the phencyclidine receptor.(1985)89 cited
• → Effect of NE-100, a novel sigma receptor ligand, on phencyclidine-induced delayed cognitive dysfunction in rats(1995)44 cited
• → Identification of Phencyclidine-Related Drugs(1977)1 cited
• → Wash-resistant inhibition of phencyclidine- and haloperidol-sensitive sigma receptor sites in guinea pig brain by putative affinity ligands: Determination of selectivity(1990)4 cited
• → NE-100, a novel sigma receptor ligand: Effects on phencyclidine-induced behaviors in experimental animals(1995)